Friday, November 15, 2024
HomeTagsDavid O'Hagan

David O'Hagan

Esperovax Signs Exclusive Agreement With the University of Michigan

Esperovax, a leading developer of oral vaccines, announced it has signed a new, exclusive licensing agreement with Innovation Partners at the University of Michigan...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics